TEH BW[au] - Search Results

Year	Number of Results
2012	4
2013	4
2014	10
2015	8
2016	5
2017	5
2018	4
2019	5
2020	8
2021	10
2022	6
2023	21
2024	3

1

Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014.

Cooley L, Dendle C, Wolf J, Teh BW, Chen SC, Boutlis C, Thursky KA. Cooley L, et al. Among authors: teh bw. Intern Med J. 2014 Dec;44(12b):1350-63. doi: 10.1111/imj.12599. Intern Med J. 2014. PMID: 25482745 Review.

2

Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2021.

Teh BW, Yeoh DK, Haeusler GM, Yannakou CK, Fleming S, Lindsay J, Slavin MA; Australasian Antifungal Guidelines Steering Committee. Teh BW, et al. Intern Med J. 2021 Nov;51 Suppl 7:67-88. doi: 10.1111/imj.15588. Intern Med J. 2021. PMID: 34937140

3

Immunoglobulin replacement in hematological malignancies: a focus on evidence, alternatives, dosing strategy, and cessation rule.

Sim B, Ng JY, Teh BW, Talaulikar D. Sim B, et al. Among authors: teh bw. Leuk Lymphoma. 2023 Jan;64(1):18-29. doi: 10.1080/10428194.2022.2131424. Epub 2022 Oct 11. Leuk Lymphoma. 2023. PMID: 36218218

4

Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis.

Reynolds G, Cliff ERS, Mohyuddin GR, Popat R, Midha S, Liet Hing MN, Harrison SJ, Kesselheim AS, Teh BW. Reynolds G, et al. Among authors: teh bw. Blood Adv. 2023 Oct 10;7(19):5898-5903. doi: 10.1182/bloodadvances.2023010539. Blood Adv. 2023. PMID: 37467036 Free PMC article.

5

Robust SARS-CoV-2 T cell responses with common TCRαβ motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells.

Nguyen THO, Rowntree LC, Allen LF, Chua BY, Kedzierski L, Lim C, Lasica M, Tennakoon GS, Saunders NR, Crane M, Chee L, Seymour JF, Anderson MA, Whitechurch A, Clemens EB, Zhang W, Chang SY, Habel JR, Jia X, McQuilten HA, Minervina AA, Pogorelyy MV, Chaurasia P, Petersen J, Menon T, Hensen L, Neil JA, Mordant FL, Tan HX, Cabug AF, Wheatley AK, Kent SJ, Subbarao K, Karapanagiotidis T, Huang H, Vo LK, Cain NL, Nicholson S, Krammer F, Gibney G, James F, Trevillyan JM, Trubiano JA, Mitchell J, Christensen B, Bond KA, Williamson DA, Rossjohn J, Crawford JC, Thomas PG, Thursky KA, Slavin MA, Tam CS, Teh BW, Kedzierska K. Nguyen THO, et al. Among authors: teh bw. Cell Rep Med. 2023 Apr 18;4(4):101017. doi: 10.1016/j.xcrm.2023.101017. Epub 2023 Mar 27. Cell Rep Med. 2023. PMID: 37030296 Free PMC article.

6

Infections in haematology patients treated with CAR-T therapies: A systematic review and meta-analysis.

Reynolds GK, Sim B, Spelman T, Thomas A, Longhitano A, Anderson MA, Thursky K, Slavin M, Teh BW. Reynolds GK, et al. Among authors: teh bw. Crit Rev Oncol Hematol. 2023 Dec;192:104134. doi: 10.1016/j.critrevonc.2023.104134. Epub 2023 Sep 20. Crit Rev Oncol Hematol. 2023. PMID: 37739146 Free article. Review.

7

Infectious complications of bispecific antibody therapy in patients with multiple myeloma.

Sim BZ, Longhitano A, Er J, Harrison SJ, Slavin MA, Teh BW. Sim BZ, et al. Among authors: teh bw. Blood Cancer J. 2023 Mar 10;13(1):34. doi: 10.1038/s41408-023-00808-8. Blood Cancer J. 2023. PMID: 36894539 Free PMC article. No abstract available.

8

COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future.

Hall VG, Teh BW. Hall VG, et al. Among authors: teh bw. J Infect Dis. 2023 Aug 4;228(Suppl 1):S55-S69. doi: 10.1093/infdis/jiad174. J Infect Dis. 2023. PMID: 37539765 Free PMC article. Review.

9

Vaccine schedule recommendations and updates for patients with hematologic malignancy post-hematopoietic cell transplant or CAR T-cell therapy.

Reynolds G, Hall VG, Teh BW. Reynolds G, et al. Among authors: teh bw. Transpl Infect Dis. 2023 Nov;25 Suppl 1(Suppl 1):e14109. doi: 10.1111/tid.14109. Epub 2023 Jul 29. Transpl Infect Dis. 2023. PMID: 37515788 Free PMC article. Review.

10

Current Epidemiology and Clinical Features of Cryptococcus Infection in Patients Without Human Immunodeficiency Virus: A Multicenter Study in 46 Hospitals in Australia and New Zealand.

Coussement J, Heath CH, Roberts MB, Lane RJ, Spelman T, Smibert OC, Longhitano A, Morrissey O, Nield B, Tripathy M, Davis JS, Kennedy KJ, Lynar SA, Crawford LC, Crawford SJ, Smith BJ, Gador-Whyte AP, Haywood R, Mahony AA, Howard JC, Walls GB, O'Kane GM, Broom MT, Keighley CL, Bupha-Intr O, Cooley L, O'Hern JA, Jackson JD, Morris AJ, Bartolo C, Tramontana AR, Grimwade KC, Au Yeung V, Chean R, Woolnough E, Teh BW, Chen SCA, Slavin MA; Australian and New Zealand Study Group for Cryptococcosis in Patients Without HIV Infection. Coussement J, et al. Among authors: teh bw. Clin Infect Dis. 2023 Oct 5;77(7):976-986. doi: 10.1093/cid/ciad321. Clin Infect Dis. 2023. PMID: 37235212

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

79 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year